Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $127.2 million.

  • Surgery Partners' Shares Outstanding (Weighted Average) rose 81.95% to $127.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $127.2 million, marking a year-over-year increase of 81.95%. This contributed to the annual value of $126.1 million for FY2024, which is 40.52% up from last year.
  • As of Q3 2025, Surgery Partners' Shares Outstanding (Weighted Average) stood at $127.2 million, which was up 81.95% from $127.0 million recorded in Q2 2025.
  • Surgery Partners' Shares Outstanding (Weighted Average)'s 5-year high stood at $127.2 million during Q3 2025, with a 5-year trough of $54.8 million in Q1 2021.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $106.4 million, with a median of $125.6 million in 2023.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 6514.13% in 2021, then soared by 33.09% in 2024.
  • Over the past 5 years, Surgery Partners' Shares Outstanding (Weighted Average) (Quarter) stood at $72.4 million in 2021, then increased by 26.96% to $92.0 million in 2022, then soared by 36.61% to $125.6 million in 2023, then rose by 0.41% to $126.1 million in 2024, then rose by 0.86% to $127.2 million in 2025.
  • Its last three reported values are $127.2 million in Q3 2025, $127.0 million for Q2 2025, and $126.6 million during Q1 2025.